跳至主要内容
临床试验/NL-OMON24569
NL-OMON24569招募中不适用

Optimal blood management in elective orthopaedic surgery. The Transfusion Op Maat (TOMaat) study.

MC, department of Orthopaedics0 个研究点目标入组 2,250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,250

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • All orthopedic patients of 18 years and older being considered for a primary or revision total knee replacement (TKR) or total hip replacement (THR).

排除标准

  • Refusal of allogeneic blood, pregnancy, patients with uncontrolled hypertension, cardiac instability, recent CVA, symptomatic atherosclerosis, sickle cell anaemia, cancer in the wound area , unsuitability for peri-operative anticoagulation prophylaxis, known allergy to erythropoietin and patients with an infected prosthesis or wound.

研究者

发起方
MC, department of Orthopaedics

相似试验

Optimal blood management in elective orthopaedic... | 临床试验